Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study. (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fonc.2019.01095
PubMed Identifier: 31737561
Publication URI: http://europepmc.org/abstract/MED/31737561
Type: Journal Article/Review
Volume: 9
Parent Publication: Frontiers in oncology
ISSN: 2234-943X